Boaz Noy, head of the BAI division, said: “As part of our strategy, we have identified several key markets such as the Australian as a keys to our global growth.
“I am glad that this strategy pays off. Indeed, we have found that leading producers were able to appreciate Enzymotec exceptional krill oil quality. This quality advantage is based primarily on Enzymotec’s exclusive MSOTM process, developed by its technical team ensuring lasting freshness and potency.”
Dr Sigalit Zchut, head of R&D, said: “Recently, Aker published a PR regarding a new patent. This patent follows the trend of krill oil-related patents, probably due to its high growth and huge potential.
“Enzymotec has been involved in the technology of producing krill oil, long before commercialisation of krill oi. This patent as well as others does not limit Enzymotec or its customers from selling krill oil in Australia.”
Source: Enzymotec
© FoodBev Media Ltd 2024